






























cCASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 25 (2016) 234–237
Contents lists available at ScienceDirect
International  Journal  of  Surgery  Case  Reports
j ourna l h om epage: www.caserepor ts .com
ntra-Aortic  Balloon  Occlusion  (IABO)  may  be  useful  for  the
anagement  of  secondary  aortoduodenal  ﬁstula  (SADF):  A  case  report
okichi  Miyamotoa,  Mototaka  Inabab,  Toru  Kojimaa,∗, Takefumi  Nigumaa,∗,
etsushige  Mimuraa,∗
Department of Surgery, Japan
Department of Emergency, Okayama Saiseikai General Hospital, 2-25 Kokutaicho, kita-ku, Okayama 7008511, Japan
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 19 March 2016
eceived in revised form 9 June 2016
ccepted 9 June 2016





a  b  s  t  r  a  c  t
INTRODUCTION:  Secondary  aortoduodenal  ﬁstula  (SADF)  is a rare  but  life-threatening  complication  after
aortic  reconstruction.  Although  a number  of  reports  describing  treatments  for SADF  have  been published,
the optimal  management  is  unclear.  A  review  of the  literature  suggested  methods  of reconstruction,
control  of bleeding,  and  reduction  of infection  in the  management  of  SADF.  The most  important  factor
for  acute  intervention  is controlling  the  bleeding  from  the  ﬁstula.  We  report  one  case  treated  using
intra-aortic  balloon  occlusion  (IABO)  for SADF.
PRESENTATION  OF  A  CASE:  We  describe  a case  of  secondary  aortoduodenal  ﬁstula  that  occurred  seven
years following  aortobifemoral  reconstruction  for abdominal  aortic  aneurysm.
DISCUSSION:  Early  control  of  bleeding  is  essential  for  survival  of  the  patient.  Emergency  laparotomy
or  endovascular  stenting  frequently  have  been  chosen  as interventions,  although  each  approach  has
signiﬁcant  limitations.  Emergency  laparotomy  for patients  with  hemodynamic  instability  may  create
excessive  physiologic  stress,  and endovascular  stenting  may  not  be  available  at  every  surgical  facility.
The  use of IABO  for cases  of  intraperitoneal  bleeding  due  to trauma  has  been  previously  described.  IABO
is relatively  easy  to  implement,  and  enabled  us  to control  the  bleeding  from  the  aorta  more  rapidly  than
other  strategies.
CONCLUSION:  Based  on a review  of  the  literature  and our  own  experience,  IABO  should  be  considered  as
one option  for  the management  of  SADF.
© 2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
he CCaccess  article  under  t
. Introduction
Aortoenteric ﬁstula occurring after aortic aneurysm repair is
n uncommon and life-threatening condition. Urgent control of
leeding is of paramount importance. We describe a case that was
anaged initially with the novel use of intra-aortic balloon occlu-
ion prior to deﬁnitive surgical intervention.
. Case report
An 80-year-old male patient with a history of surgical recon-
truction of abdominal aortic-aneurysm seven years prior was
dmitted to our hospital with melena. The melena occurred 3 hours
efore admission. The patient was not taking anticoagulant therapy
nd had no other signiﬁcant past medical history. On admission, his
bdomen was soft and ﬂat. He had no symptoms including abdom-
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inal pain, tenderness, nausea, or vomiting. There was some fresh
melanotic stool noted in digital rectal examination, but no tumor
or hemorrhoid was noted. His blood pressure was 111/55 mmHg,
heart rate was 60 beats per minute, and temperature was  35.5 ◦C.
His hemoglobin was 11.0 g/dl (Table 1). We  suspected intestinal
bleeding, but no acute intervention was planned since his vital
signs were stable. Computed tomography (CT) without intravenous
contrast did not reveal the source of melena.
Approximately 2 h after admission, the patient experienced a
rapid increase in both hematemesis and melena associated with
hypotension. (Table 2) An emergency endoscopy was performed,
revealing scars of previous ulcer disease along with blood clots
(Fig. 1), but no fresh bleeding was  noted in the stomach or duo-
denum. His blood pressure increased gradually after intravenous
ﬂuid resuscitation. Two hours later, hematemesis reoccurred, and
a second emergency endoscopy was  performed. On repeat exami-
nation, the duodenum was  full of fresh blood, making identiﬁcation
of the site in the hemorrhage impossible (Fig. 2). During the endo-
scopic procedure, the patient again developed hemorrhagic shock.
Blood pressure could not be maintained with transfusions alone,
so we decided to use intra-aortic balloon occlusion (IABO) to con-
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Table  1
Laboratory data on admission.
Laboratory data on admission
WBC  13,500 /l BUN 26 mg/dl
RBC 345 × 104 /l Cre 1.6 mg/dl
Hgb 11.0 g/dl Na 139 mEq/l
Hct  33.7 % K 4.0 mEq/l
PLT  16.3 × 104 /mm3  Cl 101 mEq/l
TP  6.7 g/dl BS 174 mg/dl
ALB  3.5 g/dl CRP 3.6 mg/dl
AST 17 IU/L BUN 26 mg/dl
ALT  10 IU/L
T-Bil 1.0 mg/dl
Fig. 1. The ﬁrst emergency endoscopy revealed scars of previous ulcer disease along
with blood clots, but no fresh bleeding was noted in the stomach or duodenum.
Table 2
Timeline from admission.Fig. 2. The second emergency endoscopy showed the duodenum was  full of fresh
blood, making identiﬁcation of the site in the hemorrhage impossible.
trol the bleeding and support the blood pressure. After insertion
of the balloon, angiography revealed extravasation of dye from the
abdominal aorta into the duodenum (Fig. 3), establishing that the
cause of bleeding was a secondary aortoenteric ﬁstula. The patient’s
vital signs gradually stabilized, and he was  taken to surgery for
urgent laparotomy.
Laparotomy revealed that there was a large blood clot in the
intestine and conﬁrmed the presence of a ﬁstula between the
graft and the third portion of duodenum but no intraabdominal
hemorrhage (Fig. 4). We  conﬁrmed the diagnosis of secondary aor-
toduodenal ﬁstula by deﬂating the balloon temporarily. No other
ﬁstulae were identiﬁed. Since there was no evidence of abscess
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developed because the area of debridement was insufﬁcient. Theig. 4. There was a ﬁstula between the proximal end of graft and the third portion
f  duodenum.
r infection around the surgical site, we debrided scar tissue near
he ﬁstula or graft, then sutured the defects of the aorta with 4-0
roline® and felt, and sutured the hole of duodenum by layer to
ayer with 4-0 polydioxanone. To prevent surgical site infection,
e wrapped the graft with the greater omentum. By the time of his
eturn to the intensive care unit, he had been transfused with 10
nits of packed red cells, 16 units of fresh frozen plasma, and 2 units
f platelet concentrates for circulatory support. Broad-spectrum
ntibiotics (biapenem, 0.6 g/day) were administered for 1 week
ost-operatively. Blood cultures remained negative.
The patient developed a high fever around 38 ◦C on day 14
ost-operatively. Contrast-enhanced computed tomography (CT)
howed an abscess near the omentum, and the patient under-PEN  ACCESS
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went percutaneous drainage. After abscess drainage and a change
in antibiotics, the abscess had resolved 2 weeks later. The patient
was discharged from the hospital on the 44th post-operative day,
and was given oral antibiotics for 6 months after discharge. At
12 months follow-up, there was  no evidence of recurrence of the
abscess.
3. Discussion
Secondary aortoenteric ﬁstula (SAEF) is one of the rare compli-
cations seen after aortic reconstruction with prosthetic implants
[1,2]. According to previous report, a small percentage of patients
may  develop SAEF following reconstruction. The interval between
reconstruction and occurrence of SAEF may  be nearly immediate or
delayed (range, 2 days to 18 years) [1–6]. The main cause of SAEF is
thought to be mechanical pressure of the graft against the bowel, or
a pseudoaneurysm due to perigraft infection or perigraft hematoma
[1]. In the current case, there was no abscess or evidence of infec-
tion around ﬁstula, making chronic inﬂammation from mechanical
pressure was  the most likely cause of his ﬁstula.
Three factors are very important for the treatment of SAEF: con-
trol of bleeding, prevention of infection, and reconstruction [1,7,8].
The most important factor for acute management is controlling the
bleeding from the ﬁstula. As seen in the present case, aortoenteric
ﬁstula (AEF) may  result in a large amount of intestinal bleeding.
Recent developments in interventional radiology have enabled us
to plan a two-stage operation, with deﬁnitive surgery delayed until
after temporary control of bleeding from the stent graft [2,9–11].
In our case, we  were not able to perform endovascular aortic repair
(EVAR), nor send him to another facility, due to his unstable condi-
tion. IABO is recognized as a feasible strategy for temporary control
for intraabdominal bleeding or shock with trauma [12–16]. IABO is
relatively easy to implement, and it enabled us to control the bleed-
ing from the aorta more easily and quickly than other strategies. In
our case, we gained immediate control of the bleeding from the
ﬁstula by using IABO, enabling us to rescue the patient.
Complications of IABO are organ’s ischemia and reperfusion
damage during inﬂation. Ishihara et al. reported that blocking the
ﬂow of aorta over 45 min  might cause irreversible dysfunction of
organs [17]. Although we should make a radical cure as soon as
possible, we can control the pressure or the place of inﬂation as we
want. In this case, the ﬁstula was mounted on the peripheral site of
the root of left renal artery, so we could inﬂate this at the appropri-
ate place without organ’s ischemia. Moreover, during laparotomy,
we could keep his blood ﬂow of the lower limbs by deﬂating the
balloon intermittently and switching to compression ﬁstula with
our hands. Several reports reveal EVAR has superiority in the man-
agement of SAEF because it enables us to control the bleeding from
ﬁstula and do deﬁnitive therapy for SAEF simultaneously. But there
are several institutions where we couldn’t choose it, IABO will be
one of the valuable tools for the urgent management of SAEF.
Prevention of infection is important in these cases [7,8].
Debridement of infected tissues, followed by appropriate antibi-
otics, help to prevent infection. In our case, there was no evidence
of infection, abscess, or infectious pseudoaneurysm, so we  debrided
only necrotic tissues and scars around the ﬁstula without replac-
ing the graft. We  sutured the each defect carefully, and wrapped
the aorta with greater omentum. We gave intravenous antibiotics
of Biapenem for a full week after surgery. However, on the 14th
post-operative day he developed a high fever over 38 ◦C, and CT
showed an abscess around the wrapped omentum. This may  haveabscess was localized in the same region we debrided, and there
was no abscess in the other regions. We believe that the abscess
was caused by bacterial migration across the ﬁstula. In cases of
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AEF, we should consider that some enteric bacteria are present in
he stent or graft even if there is no abscess or infectious aneurysm
t the time of operation.
It is also possible that the duration of intravenous antibiotics
as too short. We  gave antibiotics for one week after the operation,
uided by blood cultures. We  believed that a week was  sufﬁcient
ince there was no abscess or evidence of infection. Ohta et al. [7]
eported that their patients who had evidence of aortic graft infec-
ion received broad-spectrum antibiotics until the bacterial culture
as identiﬁed, then changed to more selective antibiotics based on
ultures and sensitivities until the C-reactive protein value normal-
zed. Those patients then received antibiotics orally for 3–6 months
fter leaving the hospital. In our case, we started antibiotics again
ntravenously after abscess drainage during the hospital stay based
n culture results, and then the patient received oral antibiotics for
nother 6 months after discharge. There was no evidence of abscess
t the end of the follow-up period.
The method of reconstruction should be selected with preven-
ion of infection in mind. Infection prevention guides decisions on
ow to remove infected grafts, infectious tissues, or scars. Some of
he strategies available for reconstruction include simple closure
f the aortic or intestinal defect, axillobifemoral bypass followed
y total excision of infected grafts, and anastomotic reconstruction
ith a new graft followed by total debridement [2,7,8], but there is
o consensus on which approach is best.
. Conclusion
Secondary aortoduodenal ﬁstula is a rare but life-threatening
omplication of aortic reconstruction. Control of bleeding is the
ost important primary step to rescue patients who develop this
readed complication. Several strategies for controlling bleeding
ave been reported, but the best method is uncertain. Intra-aortic
alloon occlusion (IABO) is a fast and effective method for stop-
ing or controlling bleeding from the ﬁstula. We  believe that IABO
hould be considered as a viable option for the urgent management
f SADF.
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